COMMUNIQUÉS West-GlobeNewswire

Alvotech Secures Settlement Agreement in Global Markets for its Biosimilar to Eylea® 2mg
29/01/2026
REYKJAVIK, ICELAND (January 29, 2026) — Alvotech (NASDAQ: ALVO), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that it has [...]
Alvotech Secures Settlement Agreement in Global Markets for its Biosimilar to Eylea® 2mg
29/01/2026
REYKJAVIK, Iceland, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today [...]
OSE Immunotherapeutics Selects Chronic Pouchitis and Hidradenitis Suppurativa as New Key Indications for Lusvertikimab
29/01/2026
OSE Immunotherapeutics Selects Chronic Pouchitis and Hidradenitis Suppurativa as New Key Indications for Lusvertikimab Development built on strong IL-7R biological rationale Chronic Pouchitis offers a capital-efficient [...]
Press release: 2025: strong sales and EPS growth. Continued profitable growth expected in 2026
29/01/2026
2025: strong sales and EPS growth. Continued profitable growth expected in 2026 Paris, January 29, 2026 Q4 sales growth of 13.3% at CER 1 and business earnings per share (EPS) 2 of €1.53 Pharma launches increased sales [...]
Communiqué de presse : 2025 : année de forte croissance du chiffre d’affaires et du BNPA. Poursuite d’une croissance rentable attendue en 2026
29/01/2026
2025 : année de forte croissance du chiffre d’affaires et du BNPA. Poursuite d’une croissance rentable attendue en 2026. Paris, le 29 janvier 2026 Ventes du T4 en progression de 13,3 % à TCC 1 et BNPA 2 des activités de [...]
OSE Immunotherapeutics sélectionne la pouchite chronique et l’hidradénite suppurée comme nouvelles indications clés pour Lusvertikimab
29/01/2026
OSE Immunotherapeutics sélectionne la pouchite chronique et l’hidradénite suppurée comme nouvelles indications clés pour Lusvertikimab Développement basé sur un fort rationnel biologique de l’IL-7R La pouchite chronique [...]
Ipsen nomme Peter Guenter au sein de son Conseil d’Administration
29/01/2026
PARIS, FRANCE, 29 janvier 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) annonce aujourd'hui la cooptation de Peter Guenter au sein de son Conseil d'Administration en tant qu'Administrateur, à compter du 28 janvier 2026, [...]
Interim Results for the six months ended 31 October 2025
29/01/2026
OXFORD, United Kingdom, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Scancell Holdings plc (AIM: SCLP), the developer of ImmunoBody ® and Moditope ® active immunotherapies to treat cancer, today announces a business update and [...]
Enterome appoints leading hematologist and IFLI Executive Partner Mehrdad Mobasher, M.D., M.P.H., to its Board of Directors
29/01/2026
Dr. Mobasher held several executive roles in industry, most recently CMO at BeiGene IFLI contributed up to $9 million to Enterome’s private funding round in 2025 Enterome has announced a series of encouraging clinical [...]
Ipsen nominates Peter Guenter to its Board of Directors
29/01/2026
PARIS, FRANCE, 29 January 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today the co-optation of Peter Guenter to its Board as a Director, effective January 28, 2026, further to the vacancy of Mr. Henri Beaufour’s [...]
[Ad hoc announcement pursuant to Art. 53 LR] Roche reports strong 2025 results with 7% sales growth
29/01/2026
Group sales grew by 7% 1 at constant exchange rates (CER; 2% in CHF), driven by strong demand for medicines and diagnostic solutions. Sales in the fourth quarter increased by 8%, reflecting the positive momentum. [...]
Ryoncil® Net Revenues Increase for the Quarter to US$30M
29/01/2026
Activity Report for Quarter Ended December 31, 2025 (Appendix 4C) NEW YORK, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory [...]
TomorrowsRx Telehealth Service Outlines Prescription Access for Compounded Semaglutide and Advanced Tirzepatide Formulations
29/01/2026
An informational overview examining what consumers often consider when researching telehealth-based prescription weight management treatment access through physician-supervised platforms SAN MARCOS, CA, Jan. 28, 2026 ( [...]
Psyence BioMed Announces Effective Date for 1-for-6.25 Reverse Stock Split
29/01/2026
NEW YORK, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“ Psyence BioMed ” or the “ Company ”), today announced the effective date of its 1-for-6.25 share consolidation (reverse stock split) [...]
L’Association canadienne pour l’équité en santé des femmes annonce une séance Conversations vitales sur les menstruations et la santé hormonale tout au long de la vie, présentée par Vichy Laboratoires
28/01/2026
Cycle menstruel, ménopause et plus encore – des expertes présenteront l’influence des hormones sur la santé des femmes à toutes les étapes de leur vie TORONTO, 28 janv. 2026 (GLOBE NEWSWIRE) -- L’Association canadienne [...]
Amneal Pharmaceuticals Added to S&P SmallCap 600® Index
28/01/2026
BRIDGEWATER, N.J., Jan. 28, 2026 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced that it has been added to the S&P SmallCap 600 ® Index. The inclusion will [...]
Future Communities Institute, with Akido Labs, Five Keys, and ReImagine Freedom Launch the Bay Area’s First AI-Powered Safety Net Program
28/01/2026
Delivering an Abundance of Personalized, High-Quality Care to the Region’s Vulnerable Communities and People Experiencing Homelessness SAN FRANCISCO, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Future Communities Institute (FCI) [...]
Park Dental Partners Expands Presence in Arizona with Addition of Ironwood Dental
28/01/2026
MINNEAPOLIS, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Park Dental Partners, Inc. (NASDAQ: PARK) (the Company), a leading dental resource organization, announced that on January 23, 2026, Ironwood Dental, located in Tucson, [...]
Women’s Health Collective Canada Announces Vital Talks Event on Menstruation and Lifelong Hormonal Health, Presented by Vichy Laboratoires
28/01/2026
From menstrual cycles to menopause and beyond – experts explore how hormones shape health at every stage of life TORONTO, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Women’s Health Collective Canada is pleased to announce the [...]

Pages